Rp-Hplc Method Development and Validation for Simultaneous Estimation of Terbinafine Hydrochloride and Fluticasone Propionate in Their Formulation | Patel | Annals of Pharma Research

User

Keywords Antibacterial Antibacterial, Chloramphenicol, Oxystelma esculentum, Pathogens, Plate hole diffusion assay. Artificial Intelligence, Clinical Trials, Healthcare Research, Big Data, Patient Recruitment, Data Privacy, Algo-rithmic Bias Bio adhesive, Drug, Polymers, Novel drug deliver, Pharmacokinetics, Pharmacodynamics COVID 19, rhino Mucormycosis, Intravenous immunoglobulin, liposomal amphotericin Endoscopic debridement Diabetes, glibenclamide, glimepiride, hypoglycemia, insulin, Libya. FGIDs, Functional Dyspepsia, Recurrent Abdominal Pain, Tri cyclic antidepressants drug, Serotonin reuptake inhibitor Gene Therapy, Cancer, Retrovirus, Hypertension Heart rate variability, elderly, autonomic dystonia syndrome Honey Hospital NCDs Non-communicable Diseases Nose, Intra-Nasal, Bioavailability, Biopharmaceutical, Mucoadhesion, Drug Delivery Systems Public Health RP-HPLC, Terbinafine Hydrochloride and Fluticasone Propionate Solubility, Ibuprofen, solution, gel Sustained release, controlled release, matrix, reservoir, diffusion Vitis vinifera, Grape seed extract, Wound healing, Antioxidant Wound autonomic dystonia syndrome, elderly people, rehabilitation program, physical rehabilitation, behavior correction

About The Authors

Grishma H. Patel
Pioneer Pharmacy Degree College, Ajwa-Nimeta road, Vadodara-390019, Gujarat, India

Faiz S. Bandwala
Pioneer Pharmacy Degree College, Ajwa-Nimeta road, Vadodara-390019, Gujrat, India

Dhananjay B. Meshram
Pioneer Pharmacy Degree College, Ajwa-Nimeta road, Vadodara-390019, Gujrat, India

Editorial Team

Indexing Status

Notifications

Journal Content
Browse

Font Size

Information

Download this PDF file

Refbacks

There are currently no refbacks.

Copyright (c) 2021 Annals of Pharma Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.